Lovastatin belongs to HMG-CoA reductase inhibitors (statins for short) and has competitive inhibitory effect on HMG-CoA reductase. Thereby reducing the levels of total cholesterol, low density lipoprotein and apolipoprotein B in blood, and playing a role in preventing and treating atherosclerosis and coronary heart disease.